Neurointervention Search


Best practice

  • HOME
  • Best practice

Principles of transparency and best practice of scholarly publishing

As an open access journal, Neurointervention will follow the Principles of Transparency and Best Practice in Scholarly Publishing ( developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

List of Contents


1. Name of Journal

The official journal title is Neurointervention (pISSN: 2093-9043, eISSN: 2233-6273).

2. Website

1) The URL address of official journal web site is

2) Aim and Scope
Neurointervention, an official journal of the Korean Society of Interventional Neuroradiology, publishes original articles documenting interventional neuroradiology. This journal was first published in 2006 under the title ‘Sin'gyŏng chungjae ch'iryo ŭihak’ and 'Neurointervention' (pISSN 1975-5643) and was renamed 'Neurointervention' in 2011 (pISSN 2093-9043, eISSN 2233-6273). Neurointervention has been published twice a year on the first day of March and September until 2019 and has been published 3 times a year on the first day of March, July, and November since 2020. Neurointervention has been published online only (eISSN 2233-6273) since March 2023 with volume 18, number 1.

The aim of the journal is to offer clinicians and researchers working in the neurointervention field peer-reviewed articles on clinical and basic investigation of the cerebral circulation and associated diseases for enhancing patient management, education, clinical or experimental research, and professionalism. Neurointervention publishes articles related to research and the practice of neurovascular diseases, including observational or outcome studies, clinical trials, epidemiology, health services, advances in applied (translational) and basic research, and current trends in cerebrovascular health issues.

The scope of the journal encompasses any areas of neurointerventional research, including those on pathophysiology, risk factors, symptomatology, imaging, and treatment. Research in basic science is considered only when it provides clinically relevant important information. Additionally, we are interested in studies that highlight characteristics of neurovascular diseases and stroke in Asian and Australasian populations. The journal publishes full-length original papers, reviews, technical notes, brief reports, case series, case reports, letters to the editor, commentaries, editorials, special reports, such as conference or meeting summaries, and medical cartoons.

The instructions for Neurointervention submissions are in accord with the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals” of the International Committee of Medical Journal Editors (ICMJE;, if not otherwise described below. Authors will be asked to confirm their compliance with the journal's policies and guidelines during manuscript submission on the web page, and each author will be asked to submit a signed "Conflicts of Interest and Copyright Transfer" document (available at Instructions & Forms at prior to acceptance of their manuscript.

3. Publishing Schedule
Neurointervention has been published twice a year on the first day of March and September until 2019 and has been published 3 times a year on the first day of March, July, and November since 2020.

4. Archiving
Full text of the Neurointervention has been archived in PubMed Central (PMC)/Europe PMC/PMC Canada ( © Korean Society of Interventional Neuroradiology from the 6th volume, 2011, National Library of Korea ( from the 11th(2) volume, 2016. According to the deposit policy (self-archiving policy) of Sherpa/Romeo (, authors cannot archive pre-print (i.e. pre-refereeing), but they can archive post-print (i.e. final draft post-refereeing). Authors can archive publisher's version/PDF. Neurointervention provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in PubMed Central and National Library of Korea.

5. Copyright

The copyrights of published manuscripts and Neurointervention online ( are held by the Korean Society of Interventional Neuroradiology. Neurointervention permanently retains the copyrights to all manuscripts published in Neurointervention (including those submitted and approved for publication but not yet published) since 2006. Every paper published in Neurointervention is freely available via our website ( The Korean Society of Interventional Neuroradiology requires the Copyright Transfer Agreement be faxed, scanned as a PDF and e-mailed, mailed to the editorial office or submitted to e-submission system ( Hand-written signatures are required. Each author must read and sign the statements in the Copyright Transfer Agreement.

6. Licensing (author for instructions)
This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (

The content from Neurointervention in part or in whole may be used, reproduced, disseminated, or displayed for non-commercial purposes. Customary bibliographic citations, including author and publisher attribution, date, article title, Neurointervention must be indicated as reference. If an original work is subsequently reproduced or disseminated not in its entirety (i.e., only in part or as a derivative work), this must be clearly indicated.

The permission MUST be obtained from the editorial office of Neurointervention ( prior to any commercial use of material from the open access version of the journal:
- Reuse of an article or articles in part or in whole in another publication (journal or book) to be sold for commercial purposes.
- The proactive supply of multiple print or electronic copies of items taken from the journal to third parties on a systematic basis for marketing purposes.
- Reuse by an author of an article in part or in whole in other publications for commercial organizations.


7. Publication Ethics and Related Editorial Policies
Neurointervention, adheres to the guidelines and best practices published by professional organizations, including ICMJE Recommendations and the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by the Committee on Publication Ethics [COPE],; the Directory of Open Access Journals; the World Association of Medical Editors [WAME], and Open Access Scholarly Publishers Association; the Directory of Open Access Journals[DOAJ]; Furthermore, all processes of handling research and publication misconduct shall follow the applicable COPE flowchart ( For the policies on the research and publication ethics not stated in these instructions, Guidelines on Good Publication ( or Good Publication Practice Guidelines for Medical Journals ( can be applied.
Manuscripts involving examinations of volunteers and patients must include a statement that the trial protocol has been approved by an institutional ethics review board (IRB) and that the subjects gave informed consent in accordance with the standards of the Declaration of Helsinki in its revised version that the World Medical Association has developed as a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and data ( Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects should not be identifiable, such that patients’ names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed.
For animal experiments, it is expected that investigators will adhere to the Guide for the Care and Use of Laboratory Animals (National Academy of Sciences; and should get approval from the Animal Care Committee of the institution where the study took place.
For policies on any issues of research and publication ethics not stated in these instructions, the Guidelines on Good Publication ( should be applied. The content of each article is the responsibility of the authors and not of Neurointervention.
Privacy Policy
Regarding privacy policy, publication consent form will be required in addition to IRB certificate and informed consent for procedure. Publication consent forms should be required for patient’s illustration in any article, especially any case report in which an individual or a group of individuals can be identified. This requirement also applies when a report involves deceased persons. Examples of identifying information are descriptions of individual case histories, photos, x-rays, or genetic pedigrees. Informed consent form for publication of Neurointervention is available at the following site at the following site and required to submit to Neurointervention in the process of article submission.
Originality and Duplicate Publication
Neurointervention only accepts manuscripts describing original research. The editorial office of Neurointervention does not accept duplicate submission or redundant publication. Redundant (or duplicate) publication is publication of a paper that overlaps substantially with one already published in print or electronic media as defined by updated ICMJE guidelines regarding allegations of scientific misconduct. If authors believe their manuscript may be redundant, they should ask about this in a letter to the editor accompanying their submission.
In that letter, they should explain how their report overlaps with already published material, or how it differs. To help the editor determine the possibility of redundant publication, a copy of such published material may also be included. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.

Manuscripts under review or published by other journals will not be accepted for publication in Neurointervention, and articles published in this journal are not allowed to be reproduced in whole or in part in any type of publication without permission of the Editorial Board. Figures and tables can be used freely if original source is verified according to Creative Commons Non-Commercial License. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from a different journal that is not open access.
How Neurointervention Handle Complaints and Appeals
The policy of Neurointervention is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. If not described below, the process of handling complaints and appeals follows the guidelines of the COPE available from:
Who Complains or Makes an Appeal?
Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases as follows: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problem.
If any individuals or institutions want to inform the cases, they can send a letter via the contact page on our website: For the complaints or appeals, concrete data with answers to all factual questions (who, when, where, what, how, why) will be provided.
Who Is Responsible to Resolve and Handle Complaints and Appeals?
The Editor, Editorial Board, or Editorial Office is responsible for them. A legal consultant or ethics editor may be able to help with the decision making.
What May Be the Consequence of Remedy?
It depends on the type or degree of misconduct. The consequence of resolution will follow the guidelines of the COPE.
Conflict of Interest
Conflict of interest exists when an author or the author’s institution, reviewer, or editor has financial or personal relationships that inappropriately influence or bias his or her actions. Such relationships are also known as dual commitments, competing interests, or competing loyalties. These relationships vary from being negligible to having a great potential for influencing judgment. Not all relationships represent true conflict of interest. On the other hand, the potential for conflict of interest can exist regardless of whether an individual believes that the relationship affects his or her scientific judgment. Financial relationships such as employment, consultancies, stock ownership, honoraria, and paid expert testimony are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, or of the science itself. Conflicts can occur for other reasons as well, such as personal relationships, academic competition, and intellectual passion ( If there are any conflicts of interest, authors should disclose them in the manuscript. The conflicts of interest may occur during the research process as well; however, it is important to provide disclosure. If there is a disclosure, editors, reviewers, and reader can approach the manuscript after understanding the situation and the background of the completed research.
Authorship Criteria
Neurointervention defines an “author” as a person whose participation in the work is sufficient for taking public responsibility for all portions of the content. To be listed as an author at byline, an individual has to meet all four categories established by ICMJE (Defining the role of authors and contributors, (1) Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; (2) Drafting the work or revising it critically for important intellectual content; (3) Final approval of the version to be published; and (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
If any persons do not meet the above criteria, they may be placed as contributors in the Acknowledgments section. Description of co-first authors or co-corresponding authors is also accepted, if the corresponding author believes that they equally contributed to the article. The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors.
Neurointervention does not allow adding authors or changing the first or the corresponding authors once its decision of ‘Accept as it is’ is made. If any author wishes to be removed from the byline, he or she should submit a letter signed by the author, as well as all other authors, indicating his or her wish to be deleted from the list of authors. Any change in the name order in the byline requires a letter signed by all authors indicting agreement with the same.
Managing Cases of Research and Publication Misconduct
When the journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by COPE ( The Editorial Board of Neurointervention will discuss the suspected cases, reach a decision, and publish errata, corrigenda, clarifications, retractions, and apologies when needed.
Editorial Responsibilities
Editorial board will continuously work for monitoring/safeguarding publication ethics: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standard; publishing corrections, clarifications, retractions and apologies when needed; no plagiarism, no fraudulent data. Editors are always keeping following responsibilities: responsibility and authority to rejected/accept article; no conflict of interest respect to articles they reject/accept; acceptance of a paper when reasonably certain; promoting publication of correction or retraction when errors are found; preservation of anonymity of reviewers.
For specific study designs, authors are encouraged to also consult the reporting guidelines relevant to their specific research design; examples include CONSORT ( for randomized trials, STROBE for observational studies (, PRISMA for systematic reviews and meta-analyses (, CARE for case reports (, and STARD for studies of diagnostic accuracy (

8. Peer Review

Screening before Review
If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions to authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (, a plagiarism-screening tool. If a too high a degree of similarity score is found, the Editorial Board will do a more profound content screening. The criterion for similarity rate for further screening is usually 15%; however, the excess amount of similarity in specific sentences may be also checked in every manuscript. The settings for Similarity Check screening are as follows: It excludes quotes, bibliography, small matches of 6 words, small sources of 1%, and the Methods section.
All submitted manuscripts will be reviewed without exception.
Number of Reviewers
At least two reviewers will be selected from the list of reviewers by the handling editors. Therefore, manuscripts are peer reviewed by at least 2 or more experts in the corresponding field. Reviewers recommended by the corresponding authors, if any, can be included as a reviewer.
Peer Review Process and the Author Response to the Reviewer Comments
The review period is 2 weeks. The first decision is usually made within a week after completion of the review.

The Editorial Board’s decision after the review will be one of followings: Accept, Minor revision, Major revision, Reject (resubmission allowed) or Rejection (no further consideration).

The Editorial Board may request the authors to revise the manuscript according to the reviewers’ comments. If there are any requests for revision of the manuscript by the reviewers, the authors should do their best to revise the manuscript. If the reviewer's opinion is not acceptable or is believed to misinterpret the data, the author should reasonably indicate that. After revising the manuscript, the author should upload the revised files with a reply to each item of the reviewer's commentary.

The decision to accept a manuscript is not based solely on the scientific validity and originality of the study content; other factors are considered, including the extent and importance of new information in the paper as compared with that in other papers being considered, the Journal's need to represent a wide range of topics, and the overall suitability for Neurointervention.

Decision letters usually, but not always, convey all factors considered for a particular decision. Occasionally, the comments to the authors may appear to be inconsistent with the editorial decision, which takes into consideration reviewers' comments to the editor, as well as the additional factors listed above. If the author(s) believe that the journal has rejected their article in error, perhaps because the reviewers have misunderstood its scientific content, an appeal may be submitted by e-mail to the editorial office ( Statistical editing is also performed if the data requires professional statistical review by a statistician. The board of editors reserves the right to edit a manuscript for phrasing, style, and overall content at any stage prior to publication, while maintaining the scientific accuracy of the manuscript.
Processing after Acceptance
If the manuscript is finally accepted, the proofreading will be sent to the corresponding author after professional manuscript editing and/or English proofreading. Proofreading should be performed again for any misspellings or errors by the authors. Before final proofreading, the manuscript may appear at the journal homepage or PubMed as an epub ahead of print with a unique DOI number for rapid communication. The epub ahead of print version will be replaced by the replacement XML file and a final PDF.
Feedback after Publication
If the authors or readers find any errors, or contents that should be revised, it can be requested from the Editorial Board. The Editorial Board may consider erratum, corrigendum or a retraction. If there are any revisions to the article, there will be a CrossMark description to announce the final draft. If there is a reader’s opinion on the published article with the form of Letter to the editor, it will be forwarded to the authors. The authors can reply to the reader’s letter. Letter to the editor and the author’s reply may be also published.
Policy of dealing with in-house submissions
All manuscripts from editors, employees, or editorial board members are processed the same way as other unsolicited manuscripts. During the review process, they will not engage in the selection of reviewers and the decision process. Editors will not handle their own manuscripts even if they are commissioned ones.

9. Access
Neurointervention is available free in electronic form at All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


10. Ownership and Management

Information about the Ownership
This journal is owned by the publisher, the Korean Society of Interventional Neuroradiology (
Management Team of the Journal (2018~)
Dae Chul Suh, Editor-in-Chief of Neurointervention, GangNam St. Peter’s Hospital, Seoul, Korea
Sang Hyun Suh, MD, the next EIC of Neurointervention, Gangnam Severance Hospital, Korea
Associate Editors
• Dong Joon Kim, MD, Severance Hospital, Korea
• Bum-Soo Kim, MD, Seoul St. Mary’s Hospital, Korea
Assistant Editors
• Jang-Hyun Baek, MD, Kangbuk Samsung Hospital, Korea
• Hong Jun Jeon, MD, Kangdong Sacred Heart Hospital, Korea
• Jin Wook Baek, MD, Inje University Busan Paik Hospital, Korea
• Yunsun Song, MD, Asan Medical Center, Korea

- Statistics Editor: Minkyu Han, Hana Institute of Technology
- Manuscript Editor: MEDrang Inc, Korea (
- Layout Editor: JIN Publishing & Communication, Korea (
- Website and JATS XML File Producers: M2Pi (
- Administrative assistants: Min Jung Kim in the KSIN Society office & Alice Yoon (Eun Ja Yoon in Korean) in Editorial office

11. Advisory Body
The advisory body is the journal's editorial board. The full names and affiliations of the journal’s editors are displayed on the About (Editorial Board) tab of the journal website.

12. Editorial Team and Contact Information

Korean Society of Interventional Neuroradiology
Dae Chul Suh, MD
Editorial Office


13. Author Fees

There is no author’s submission fee or other publication-related fee since all costs of the publication process are underwritten by the Korean Society of Interventional Neuroradiology. Neurointervention is a diamond open access journal that does not charge author fees.

14. Other Revenue
Revenue sources of journal were from the support of publisher (the Korean Society of Interventional Neuroradiology), government’s support (the Korean Federation of Science and Technology Societies) and advertising rates. The Editorial Board ensures that business models or revenue streams do not influence the decision to accept manuscripts.

15. Advertising

Eligibility of the Advertised Products or Services
All products or services should be safe and reliable, and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant for authors, editors, reviewers, and readers. Imaging devices and pharmaceutical products including contrast materials may also be considered.
• Advertising is separate from contents of the journal. AdAdvertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
• Editorial board reserve the right to decline or cancel any advertisement at any time.
• Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.
Any individuals or organizations who are interested in advertising their products or services in the print copies of the journal or on its website are encouraged to contact the editorial office. The acceptance of advertisement will be discussed by the editorial board and will be ultimately approved by the publisher.
Advertisement Fee
Regarding the advertisement price Neurointervention follows in accordance with the Korea Research-based Pharmaceutical Industry Association (KRPIA) Fair Competition Code and Working Guideline.
Liability: Neither the publisher nor the editors will be legally liable for advertisements presented in the journal. In addition, they cannot guarantee the accuracy, completeness, or usefulness of the information provided.
Endorsement: The publisher and the editors do not endorse any products or services that are advertised.
Disclaimer: Neither the publisher nor the authors will be legally liable for any of the content of advertisements, so readers must keep this in mind when reading or seeing advertisements.

16. Direct Marketing

Journal propagation has been done through the journal website and distribution of an introduction pamphlet at the domestic as well as international conferences. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops or on the renowned authors if the topic is related to the journal's aims and scope.

  • PubMed Central
  • PubMed
  • Scopus
  • Embase
  • Directory of Open Access Journals (DOAJ)
  • KoreaMed
  • Synapse
  • KoMCI
  • GoogleScholar
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • metadata
  • FaceBook


Browse all articles >

Editorial Office
#705-2C, 9 Gangnam-ro, Giheung-gu, Yongin-si, Gyeonggi-do 16977, KOREA
Tel: +82-31-994-4382    Fax: +82-2-2275-9198    E-mail:                

Copyright © 2024 by Korean Society of Interventional Neuroradiology.

Developed in M2PI

Close layer
prev next